NCT07720674 SEE FAR CBT Intervention for Adults With PTSD
| NCT ID | NCT07720674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Community Stress Prevention Center |
| Condition | Post Traumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-07 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-07 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This single-arm clinical intervention study evaluates a 12-session SEE FAR CBT intervention for adults aged 18 years and older with posttraumatic stress disorder (PTSD). SEE FAR CBT is a trauma-focused cognitive-behavioral treatment approach. Participants will complete self-report psychological questionnaires at three time points: baseline, after completion of the intervention, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms and related psychological outcomes over the course of treatment and follow-up.
Eligibility Criteria
Inclusion Criteria Participants must meet all of the following criteria: * Age 18 years or older * PTSD symptoms, defined as a PCL-5 score of 30 or above * Able to provide informed consent * Willing and able to participate in 12 weekly individual therapy sessions and complete study questionnaires at baseline, post-intervention, and 3-month follow-up Exclusion Criteria Participants will be excluded if they meet any of the following criteria: * Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes. * Currently receiving psychotherapy of any type that began less than 3 months prior to enrolment. * Initiation of psychiatric medication less than 3 months prior to enrolment.
Contact & Investigator
Meital Mashash, PhD
PRINCIPAL INVESTIGATOR
Community Stress Prevention Center
Frequently Asked Questions
Who can join the NCT07720674 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07720674 currently recruiting?
Yes, NCT07720674 is actively recruiting participants. Contact the research team at meitalm@icspc.org for enrollment information.
Where is the NCT07720674 trial being conducted?
This trial is being conducted at Kiryat Shmona, Israel.
Who is sponsoring the NCT07720674 clinical trial?
NCT07720674 is sponsored by Community Stress Prevention Center. The principal investigator is Meital Mashash, PhD at Community Stress Prevention Center. The trial plans to enroll 60 participants.